Pharmacotherapy of aphasia: Myth or reality?

Xavier de Boissezon, Patrice Peran, Chloé de Boysson, Jean François Démonet

Research output: Contribution to journalArticle

Abstract

Pharmacotherapy of aphasia had been discussed for the last twenty years with first bromocriptine and amphetamine and then serotoninergic, GABAergic and cholinergic agents. Here, we reviewed the MEDLINE available reports of drug therapy for aphasia. So far, proofs of efficiency were found indubitable for none of the studied molecules. However, some of them showed limited efficiency (piracetam and amphetamine). Moreover, drug therapies for aphasia were less efficient alone than when they were associated with speech therapy.

Original languageEnglish
Pages (from-to)114-125
Number of pages12
JournalBrain and Language
Volume102
Issue number1
DOIs
Publication statusPublished - Jul 2007

Keywords

  • Aphasia
  • Drug therapy
  • Pharmacological treatment
  • Pharmacotherapy
  • Stroke

ASJC Scopus subject areas

  • Language and Linguistics
  • Experimental and Cognitive Psychology
  • Neuropsychology and Physiological Psychology
  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Pharmacotherapy of aphasia: Myth or reality?'. Together they form a unique fingerprint.

  • Cite this

    de Boissezon, X., Peran, P., de Boysson, C., & Démonet, J. F. (2007). Pharmacotherapy of aphasia: Myth or reality? Brain and Language, 102(1), 114-125. https://doi.org/10.1016/j.bandl.2006.07.004